Proapoptotic IL-18 in patients with chronic hepatitis C treated with pegylated interferon-alpha
✍ Scribed by He YingLi; Lin Shumei; Yang Qian; Chen Tianyan; Zhao Yingren; Chen Wei
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 295 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0372-8722
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The effect of α‐interferon on the hepatitis C genotypes was examined in 25 anti‐HCV‐positive hemophilic patients. The rate of multiple HCV genotypes in patients who are likely to have mixed infections was also studied. Pretreatment results showed that 3/25 (12%) patients had a change in
## Abstract Hepatitis C virus (HCV), a positive stranded RNA virus, is the main causative agent of post‐transfusion and sporadic non‐A non‐B hepatitis worldwide. Paired samples of plasma and peripheral blood mononuclear cells (PBMC) from 11 patients with chronic hepatitis C treated with α‐interfero
## Abstract In order to assess the efficacy of interferon‐α on hepatitis C viral RNA in patients with chronic hepatitis C, we analyzed the levels of HCV RNA in sera and liver tissues of 16 patients pre‐ and posttreatment using a semiquantitative polymerase chain reaction method. Fifteen of 16 patie
accurate representation of the data is given in Table 1. 7. The major conclusion of this paper was that monitoring hepatitis C virus RNA levels and varying the duration of therapy can save resources without sacrificing rates of SVR. The authors used the Blackwelder test to test the noninferiority of